Biotech firm seeks to advance novel exosome isolation-based therapy for COVID-19 into clinical trials

By Tommy Felts | March 28, 2020

Editor’s note: The following is part of Startland News’ ongoing coverage of the impact of Coronavirus (COVID-19) on Kansas City’s entrepreneur community, as well as how innovation is helping to drive a new normal in the ecosystem. Click here to follow related stories as they develop. [divide] As the global Coronavirus (COVID-19) outbreak grows, Clara Biotech…

Read More